Skip to main content
SpringerLink
Log in

Can dopamine agonists prevent postoperative remnant enlargement in nonfunctioning pituitary adenomas?

  • Practice Point
  • Published:

From Nature Clinical Practice Endocrinology & Metabolism

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bevan JS et al. (1992) Dopamine agonists and pituitary tumor shrinkage. Endocrine Rev 13: 220–240

    Article  CAS  Google Scholar 

  2. Greenman Y et al. (2003) Post-operative surveillance of clinically non-functioning pituitary macroadenomas: markers of tumour quiescence and regrowth. Clin Endocrinol 58: 763–769

    Article  CAS  Google Scholar 

  3. Renner U et al. (1998) Heterogeneous dopamine D2 receptor subtype messenger ribonucleic acid expression in clinically non-functioning pituitary adenomas. J Clin Endocrinol Metab 83: 1368–1375

    CAS  PubMed  Google Scholar 

  4. Pivonello R et al. (2004) Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment. J Clin Endocrinol Metab 89: 1674–1683

    Article  CAS  Google Scholar 

  5. Van Schaardenburg et al. (1989) Bromocriptine therapy for non-functioning pituitary adenoma. Clin Endocrinol 30: 475–484

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Consultant Endocrinologist at the Aberdeen Royal Infirmary and an Honorary Senior Lecturer at the University of Aberdeen, UK

    John S Bevan

Authors
  1. John S Bevan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John S Bevan.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bevan, J. Can dopamine agonists prevent postoperative remnant enlargement in nonfunctioning pituitary adenomas?. Nat Rev Endocrinol 2, 10–11 (2006). https://doi.org/10.1038/ncpendmet0049

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0049

  • Springer Nature Limited

Search

Navigation